The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ERIC 2022 | Updates on the ERIC recommendations for immunoglobulin gene sequence analysis in CLL
Andreas Agathangelidis, PhD, Center for Research and Technology Hellas, Thermi, Greece, gives an update on the latest ERIC recommendations for immunoglobulin (IG) gene sequence analysis in chronic lymphocytic leukemia (CLL) which are focused on patients with nonproductive rearrangements and on how to interpret next-generation sequencing (NGS) results. This interview took place at the 2022 European Research Initiative on CLL (ERIC) Meeting.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
